| Year |
Citation |
Score |
| 2004 |
Cryan JF, O'Leary OF, Jin SH, Friedland JC, Ouyang M, Hirsch BR, Page ME, Dalvi A, Thomas SA, Lucki I. Norepinephrine-deficient mice lack responses to antidepressant drugs, including selective serotonin reuptake inhibitors. Proceedings of the National Academy of Sciences of the United States of America. 101: 8186-91. PMID 15148402 DOI: 10.1073/Pnas.0401080101 |
0.719 |
|
| 2002 |
Page ME, Cryan JF, Sullivan A, Dalvi A, Saucy B, Manning DR, Lucki I. Behavioral and neurochemical effects of 5-(4-[4-(5-Cyano-3-indolyl)-butyl)-butyl]-1-piperazinyl)-benzofuran-2-carboxamide (EMD 68843): a combined selective inhibitor of serotonin reuptake and 5-hydroxytryptamine(1A) receptor partial agonist. The Journal of Pharmacology and Experimental Therapeutics. 302: 1220-7. PMID 12183683 DOI: 10.1124/Jpet.102.034280 |
0.619 |
|
| 2002 |
Conti AC, Cryan JF, Dalvi A, Lucki I, Blendy JA. cAMP response element-binding protein is essential for the upregulation of brain-derived neurotrophic factor transcription, but not the behavioral or endocrine responses to antidepressant drugs. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 22: 3262-8. PMID 11943827 DOI: 10.1523/Jneurosci.22-08-03262.2002 |
0.665 |
|
| 2002 |
Graves L, Dalvi A, Lucki I, Blendy JA, Abel T. Behavioral analysis of CREB alphadelta mutation on a B6/129 F1 hybrid background. Hippocampus. 12: 18-26. PMID 11918283 DOI: 10.1002/Hipo.10003 |
0.564 |
|
| 2001 |
Mayorga AJ, Dalvi A, Page ME, Zimov-Levinson S, Hen R, Lucki I. Antidepressant-like behavioral effects in 5-hydroxytryptamine(1A) and 5-hydroxytryptamine(1B) receptor mutant mice. The Journal of Pharmacology and Experimental Therapeutics. 298: 1101-7. PMID 11504807 |
0.579 |
|
| 2001 |
Cryan JF, Dalvi A, Jin SH, Hirsch BR, Lucki I, Thomas SA. Use of dopamine-beta-hydroxylase-deficient mice to determine the role of norepinephrine in the mechanism of action of antidepressant drugs. The Journal of Pharmacology and Experimental Therapeutics. 298: 651-7. PMID 11454927 |
0.668 |
|
| 2001 |
Lucki I, Dalvi A, Mayorga AJ. Sensitivity to the effects of pharmacologically selective antidepressants in different strains of mice. Psychopharmacology. 155: 315-22. PMID 11432695 DOI: 10.1007/S002130100694 |
0.59 |
|
| 2000 |
Yang J, Wu J, Kowalska MA, Dalvi A, Prevost N, O'Brien PJ, Manning D, Poncz M, Lucki I, Blendy JA, Brass LF. Loss of signaling through the G protein, Gz, results in abnormal platelet activation and altered responses to psychoactive drugs. Proceedings of the National Academy of Sciences of the United States of America. 97: 9984-9. PMID 10954748 DOI: 10.1073/Pnas.180194597 |
0.522 |
|
| 2000 |
Lucki I, Cryan JF, Kirby LG, Dalvi A. The role of norepinephrine and serotonin in behavioral models of depression Psychoneuroendocrinology. 25: S23. DOI: 10.1016/S0306-4530(00)90103-3 |
0.689 |
|
| 1999 |
Page ME, Detke MJ, Dalvi A, Kirby LG, Lucki I. Serotonergic mediation of the effects of fluoxetine, but not desipramine, in the rat forced swimming test. Psychopharmacology. 147: 162-7. PMID 10591883 DOI: 10.1007/S002130051156 |
0.694 |
|
| 1999 |
Dalvi A, Lucki I. Murine models of depression. Psychopharmacology. 147: 14-6. PMID 10591858 DOI: 10.1007/S002130051131 |
0.544 |
|
| 1999 |
Dalvi A, Rodgers RJ. Behavioral effects of diazepam in the murine plus-maze: flumazenil antagonism of enhanced head dipping but not the disinhibition of open-arm avoidance. Pharmacology, Biochemistry, and Behavior. 62: 727-34. PMID 10208379 DOI: 10.1016/S0091-3057(98)00220-2 |
0.355 |
|
| Show low-probability matches. |